Mounjaro Obesity

Your guide to
MOUNJARO^® and the KwikPen^® device

WEIGHT MANAGEMENT

Your healthcare professional may prescribe Mounjaro together with a reduced-calorie diet and increased physical activity for weight loss and to help keep your weight under control if you are an adult, who has:

A body mass index (BMI) ^a of 30 kg/m² or greater (obesity) or
A BMI of at least 27 kg/m² but less than 30 kg/m² (overweight) and weight-related health problems (such as prediabetes, type 2 diabetes, high blood pressure, abnormal levels of fats in the blood, breathing problems during sleep called ‘obstructive sleep apnoea’ or a history of heart attack, stroke or blood vessel problems).

Do not use Mounjaro:

If you are allergic to Mounjaro or any of the other ingredients of this medicine (listed in section 6 of your Patient Information Leaflet (PIL)).

^aBMI is a measure of your weight in relation to your height.

This website is produced by Eli Lilly and Company, the manufacturer of this medicine.

This information does not replace the Patient Information Leaflet (PIL) or the Instructions for Use (IFU) that come with your medicine. Please read the PIL and IFU carefully.

Watch a video on how to use the MOUNJARO KWIKPEN

This medicine is subject to additional monitoring.
This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects. Click here for the information on how to report side effects at the bottom of the page.

PP-TR-GB-1097 April 2025

Resources

Your guide to MOUNJARO ^® (tirzepatide) and the KwikPen device

Download Patient Brochure

Watch a video on how to use the Mounjaro KwikPen

Instructions for Use
Patient Information Leaflet

REPORTING SIDE EFFECTS

SIDE EFFECTS AND PRODUCT COMPLAINTS SHOULD BE REPORTED

If you experience side effects talk to your doctor or other healthcare professional. This includes any possible side effects not listed in the package leaflet. To report a side effect or product complaint with a Lilly product please call Lilly on 01256 315 000. Additionally reporting forms and further information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of medicines.

Mounjaro^®, KwikPen^® and Lilly are registered trademarks of Eli Lilly and Company.
This website is published by Eli Lilly and Company, the manufacturer of this medicine, and is intended for people prescribed Mounjaro in 'the United Kingdom.

Reporting Side Effects

You are now leaving obesity.mounjaro.co.uk

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Eli Lilly and Company and its affiliates do not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Eli Lilly and Company and its affiliates. Eli Lilly and Company and its affiliates are not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.